ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+20.38%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$371M
AUM Growth
+$371M
(+51%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
24.75%
Top 10 Holdings %
Top 10 Hldgs %
75.81%
Holding
77
New
9
Increased
15
Reduced
7
Closed
9
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$71.8M |
| 2 |
Indaptus Therapeutics
INDP
|
$20.8M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$11.2M |
| 4 |
Amicus Therapeutics
FOLD
|
$4.52M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.34M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$15.4M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
$7.78M |
| 3 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$4.47M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$4.41M |
| 5 |
AnaptysBio
ANAB
|
$3.97M |
Sector Composition
| 1 | Healthcare | 70.42% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $94.2M | 16.88% | 6,737,706 +5,137,706 | +321% | +$71.8M |
|
2
Assembly Biosciences
ASMB
$190M
| $34.9M | 6.26% | 1,000,000 -30,072 | -3% | -$1.05M |
|
3
Veracyte
VCYT
$2.39B
| $28.9M | 5.18% | 3,295,111 +214,966 | +7% | +$1.89M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $26.6M | 4.77% | 3,431,809 +16,765 | +0.5% | +$130K |
|
|
5
Indaptus Therapeutics
INDP
$7.19M
| $24.4M | 4.37% | 2,724,283 +2,324,283 | +581% | +$20.8M |
|
6
IRIDEX
IRIX
$22.8M
| $18.7M | 3.36% | 2,000,000 +262,460 | +15% | +$2.46M |
|
|
7
Ascendis Pharma
ASND
$11.8B
| $18.1M | 3.25% | 500,000 -424,483 | -46% | -$15.4M |
|
8
PDS Biotechnology
PDSB
$57.8M
| $13.4M | 2.41% | 1,253,394 -251,218 | -17% | -$2.7M |
|
|
KDMN
9
DELISTED
Kadmon Holdings, Inc.
KDMN
| $11.2M | 2% | +3,333,333 | New | +$11.2M |
|
|
CEMI
10
DELISTED
Chembio diagnostics, Inc.
CEMI
| $10.7M | 1.91% | 1,721,299 +362,948 | +27% | +$2.25M |
|
|
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
| $8.76M | 1.57% | 250,000 -51,700 | -17% | -$1.81M |
|
|
DBVT
12
DBV Technologies
DBVT
$264M
| $8.15M | 1.46% | 192,000 +84,235 | +78% | +$3.57M |
|
13
Evolent Health
EVH
$1.12B
| $8.01M | 1.44% | 450,000 +169,400 | +60% | +$3.02M |
|
|
VRAY
14
DELISTED
ViewRay, Inc.
VRAY
| $7.67M | 1.37% | 1,331,983 +645,596 | +94% | +$3.72M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $6.4M | 1.15% | 170,000 -80,000 | -32% | -$3.01M |
|
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.22M | 0.94% | 996,300 +827,615 | +491% | +$4.34M |
|
|
NVTA
17
DELISTED
Invitae Corporation
NVTA
| $4.95M | 0.89% | 528,000 +427,708 | +426% | +$4.01M |
|
18
argenx
ARGX
$43.6B
| $4.89M | 0.88% | 216,255 +63,418 | +41% | +$1.43M |
|
|
CASM
19
DELISTED
CAS Medical Systems, Inc.
CASM
| $4.69M | 0.84% | 5,093,276 +333,125 | +7% | +$306K |
|
|
20
Amicus Therapeutics
FOLD
$2.34B
| $4.52M | 0.81% | +300,000 | New | +$4.52M |
|
|
VIVE
21
DELISTED
VIVEVE MED INC
VIVE
| $4.34M | 0.78% | 827,340 +117,340 | +17% | +$615K |
|
|
NBRV
22
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $3.28M | 0.59% | 400,000 -545,737 | -58% | -$4.47M |
|
23
Forte Biosciences
FBRX
$137M
| $3.13M | 0.56% | +251,112 | New | +$3.13M |
|
|
QTNT
24
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.81M | 0.5% | 569,145 +17,949 | +3% | +$88.5K |
|
25
Fennec Pharmaceuticals
FENC
$247M
| $2.77M | 0.5% | +250,000 | New | +$2.77M |
|